Point72 Middle East FZE’s Opko Health OPK Stock Holding History

Point72 Middle East FZE’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-52,710	Closed	-$114K	–	1752
2023 Q2	$114K	Buy	+52,710	New	+$82.5K	﹤0.01%	1187

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Point72 Middle East FZE's OPK Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Opko Health (OPK) in Q3 2023, closing a stake of 52,710 shares — an estimated $114K sold.

Point72 Middle East FZE first reported a position in OPK in Q2 2023 and held it in 1 quarter. The position peaked at $114K in Q2 2023. 225 funds tracked by Wall St. Rank hold OPK as of Q3 2023.

Point72 Middle East FZE reported no remaining Opko Health position as of Q3 2023 after selling out during the quarter.
Point72 Middle East FZE sold 52,710 Opko Health shares in Q3 2023, an estimated $114K.
Point72 Middle East FZE first reported a position in Opko Health in Q2 2023 and held it in 1 quarter.
Point72 Middle East FZE's Opko Health position peaked at $114K in Q2 2023.
225 funds tracked by Wall St. Rank held Opko Health as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.